We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Affordable Coagulation Analyzers Provide Broad Testing Range

By LabMedica International staff writers
Posted on 27 Jan 2015
The most common coagulation tests performed include PT, aPTT, and D Dimer. More...
While in some labs there is a need for PT, aPTT, D Dimer, and fibrinogen, others such as (component separation) blood banks routinely perform fibrinogen and Factor VIII. Another customer set, specializing in coagulopathy, tests for certain rare parameters. However, not all available systems are equipped to cater to these requirements. Also in need of immediate attention are: not having small reagent pack sizes for D Dimer and unavailability of timely service in remote areas.

Towards resolution of these critical issues and catering to diverse customer needs, Transasia Bio-Medicals Ltd (Mumbai, India), launched two advanced coagulation analyzers: ERBA ECL 105 – Single Channel and ERBA ECL 412 – Four Channel. Both analyzers use an innovative technology thereby providing highly accurate and precise results at affordable cost.

Both instruments include the following key highlights and features: LCD touchscreen graphical display; built-in incubator for cuvette; facility for reagent incubation through magnetic stirring of reagents (especially beneficial for mixing silica or latex based reagents as they require constant stirring to maintain suspension of particulate matter); inbuilt robust thermal printer; Connectivity through USB ports, ethernet ports, and RFID detection facility; storage of data and coagulation clotting curves is possible on an external drive. The test menu includes comprehensive range of tests from clotting to chromogenic (only onECL 412) and immunologic tests; light scattering principle is used for performing assays - Clotting (640 nm), Chromogenic (405 nm), and D Dimer (800 nm). The software is user-friendly, with minimal, simple logical inputs in programming tests, multi-standard calibration, plotting multilevel quality control (QC) points, and running tests. It also includes proven technology of coagulation curve in percentage light scatter for clot detection.

The ERBA ECL 105/412 performs comprehensive coagulation tests in semiautomated systems. The tests (such as fibrinogen, factors assays, Lupus anticoagulant, AT III (only on ECL 412), Protein C, Protein S, and D Dimer) are programmed and can be performed with minimum effort. The QC plotting has been programmed keeping in mind the accreditation requirement of laboratory. Multilevel QC for each test is possible, a feature still rare in many single- and four-channel analyzers.

Related Links:

Transasia Bio-Medicals



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Multi-Chamber Washer-Disinfector
WD 390
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.